Factors associated with colorectal cancer screening adherence and the impact of COVID-19 on screening patterns in Connecticut, USA
- PMID: 35922730
- PMCID: PMC9362104
- DOI: 10.1007/s11739-022-03053-2
Factors associated with colorectal cancer screening adherence and the impact of COVID-19 on screening patterns in Connecticut, USA
Abstract
Colorectal cancer (CRC) is one of the leading causes of cancer death worldwide. Many communities remain under the 80% CRC screening goal. We aimed to identify factors associated with non-adherence to CRC screening and to describe the effect of the COVID-19 pandemic in CRC screening patterns. A retrospective review of patients aged 50-75 years seen at the Griffin Faculty Physicians primary care offices between January 2019 and December 2020 was performed. Logistic regression models were used to identify factors associated with CRC screening non-adherence. Of 12,189 patients, 66.2% had an updated CRC screen. On univariable logistic regression, factors associated with CRC screening non-adherence included age ≤ 55 years [odds ratio (OR) 2.267, p < 0.001], White/Caucasian race (OR 0.858, p = 0.030), Medicaid insurance (OR 2.097, p < 0.001), morbid obesity (OR 1.436, p < 0.001), current cigarette smoking (OR 1.849, p < 0.001), and elevated HbA1c (OR 1.178, p = 0.004). Age, Medicaid insurance, morbid obesity, current smoking, and HbA1c ≥ 6.5% remained significant in the final multivariable model. Compared to 2019, there was an 18.2% decrease in the total number of CRC screening tests in 2020. The proportion of colonoscopy procedures was lower in 2020 compared to the proportion of colonoscopy procedures conducted in 2019 (65.9% vs 81.7%, p < 0.001), with a concurrent increase in stool-based tests. CRC screening rates in our population are comparable to national statistics but below the 80% goal. COVID-19 affected CRC screening. Our results underscore the need to identify patient groups most vulnerable to missing CRC screening and highlight the importance of stool-based testing to bridge screening gaps.
Keywords: COVID-19; Cancer screening; Cologuard; Colonoscopy; FIT-DNA.
© 2022. The Author(s), under exclusive licence to Società Italiana di Medicina Interna (SIMI).
Conflict of interest statement
This research project was supported by the Health Resources and Services Administration (HRSA) Preventive Medicine Grant (D33HP31664‐05‐00) and the American Cancer Society (ACS) Physician Training Award in Cancer Prevention (134129-PTAPM-19-186-18-PTAPM). The authors declare that they have no conflicts of interest.
Figures
Similar articles
-
[Évaluation de la gravité du cancer colorectal dépisté dans le contexte de la crise sanitaire liée au COVID19 en région Ile-de-France].Rev Epidemiol Sante Publique. 2023 Oct;71(5):102124. doi: 10.1016/j.respe.2023.102124. Epub 2023 Jun 26. Rev Epidemiol Sante Publique. 2023. PMID: 37451076 Free PMC article. French.
-
Impact of social determinants of health on colorectal cancer screening and surveillance in the COVID reopening phase.Eur J Gastroenterol Hepatol. 2022 Jul 1;34(7):739-743. doi: 10.1097/MEG.0000000000002350. Epub 2022 Jan 31. Eur J Gastroenterol Hepatol. 2022. PMID: 35102113 Free PMC article.
-
A delay in the diagnosis of colorectal cancer screened by fecal immunochemical tests during the COVID-19 pandemic: a longitudinal cohort study.Int J Colorectal Dis. 2022 Dec;37(12):2543-2546. doi: 10.1007/s00384-022-04270-z. Epub 2022 Nov 16. Int J Colorectal Dis. 2022. PMID: 36383225 Free PMC article.
-
Colorectal cancer screening: An updated review of the available options.World J Gastroenterol. 2017 Jul 28;23(28):5086-5096. doi: 10.3748/wjg.v23.i28.5086. World J Gastroenterol. 2017. PMID: 28811705 Free PMC article. Review.
-
Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.Am J Gastroenterol. 2018 Dec;113(12):1778-1787. doi: 10.1038/s41395-018-0212-7. Epub 2018 Aug 29. Am J Gastroenterol. 2018. PMID: 30158713 Free PMC article.
Cited by
-
Multi-level predictors of being up-to-date with colorectal cancer screening.Cancer Causes Control. 2023 Dec;34(Suppl 1):187-198. doi: 10.1007/s10552-023-01723-w. Epub 2023 Jun 7. Cancer Causes Control. 2023. PMID: 37285065 Free PMC article.
-
Noteworthy impacts of COVID-19 pandemic on cancer screening: A systematic review.Fundam Res. 2024 Feb 8;4(3):484-494. doi: 10.1016/j.fmre.2023.12.016. eCollection 2024 May. Fundam Res. 2024. PMID: 38933198 Free PMC article. Review.
References
-
- CDC Colorectal (colon) cancer. https://www.cdc.gov/cancer/colorectal/statistics/index.htm. Accessed 1 Aug 2020
-
- American Cancer Society (2016) Key statistics for colorectal cancer. https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html. Accessed 2 Feb 2022
-
- Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, Jr, Garcia FAR, Gillman MW, Harper DM, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Owens DK, Phillips WR, Phipps MG, Pignone MP, Siu AL. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2016;315(23):2564–2575. doi: 10.1001/jama.2016.5989. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical